Your browser is no longer supported. Please, upgrade your browser.
Settings
PAVM PAVmed Inc. daily Stock Chart
PAVM [NASD]
PAVmed Inc.
Index- P/E- EPS (ttm)-0.63 Insider Own5.30% Shs Outstand33.84M Perf Week66.67%
Market Cap104.90M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float26.21M Perf Month109.46%
Income-17.30M PEG- EPS next Q-0.11 Inst Own6.50% Short Float2.85% Perf Quarter240.66%
Sales- P/S- EPS this Y-9.30% Inst Trans3.97% Short Ratio0.79 Perf Half Y216.29%
Book/sh-0.13 P/B- EPS next Y33.30% ROA-284.70% Target Price3.00 Perf Year213.51%
Cash/sh0.12 P/C25.59 EPS next 5Y- ROE351.50% 52W Range0.81 - 3.09 Perf YTD158.33%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High0.45% Beta1.36
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin- 52W Low282.72% ATR0.23
Employees9 Current Ratio0.60 Sales Q/Q- Oper. Margin- RSI (14)91.18 Volatility19.51% 10.76%
OptionableNo Debt/Eq- EPS Q/Q18.60% Profit Margin- Rel Volume2.02 Prev Close2.86
ShortableYes LT Debt/Eq- EarningsMar 05 AMC Payout- Avg Volume944.77K Price3.10
Recom2.00 SMA2074.57% SMA50120.57% SMA200179.47% Volume1,909,454 Change8.58%
Jun-28-18Initiated Maxim Group Buy $5
Feb-20-20 09:30AM  PAVmed Subsidiary Lucid Diagnostics Partners with Fred Hutchinson Cancer Research Center to Evaluate Barretts Esophagus (BE) Progression Biomarkers Using EsoCheck GlobeNewswire
Feb-18-20 09:30AM  PAVmed Adds EsoCure Esophageal Ablation Device with Patented Caldus Technology to Commercial Product Pipeline GlobeNewswire
Feb-12-20 09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga +7.69%
Feb-11-20 09:30AM  U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test GlobeNewswire +14.97%
Jan-14-20 07:55AM  The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga
Jan-13-20 09:30AM  PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance GlobeNewswire -7.79%
Dec-19-19 09:30AM  PAVmed Subsidiary Lucid Diagnostics Announces Commercial Launch of EsoGuard Esophageal DNA Test GlobeNewswire
Dec-16-19 06:16PM  Edited Transcript of PAVM earnings conference call or presentation 21-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-13-19 09:30AM  PAVmed Provides Update on CarpX Clinical Safety Study GlobeNewswire +9.41%
Nov-29-19 10:37PM  Is PAVmed Inc. (PAVM) A Good Stock To Buy? Insider Monkey
Nov-21-19 04:00PM  PAVmed Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.18%
Nov-14-19 09:30AM  PAVmed Partners with Laser Technology Pioneer Dr. Jacob Wong to Develop and Commercialize Non-Invasive Laser-based Diagnostic Products GlobeNewswire
Nov-07-19 09:30AM  PAVmeds PortIO Intraosseous Infusion System Achieves Multiple Milestones GlobeNewswire
Nov-06-19 09:30AM  PAVmed to Hold Business Update Conference Call on November 21, 2019 GlobeNewswire
Nov-05-19 07:00AM  PAVmed Secures Financing up to $14 Million for Advancement of its Lead Products to Commercialization GlobeNewswire
Sep-20-19 05:43AM  Edited Transcript of PAVM earnings conference call or presentation 5-Sep-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-05-19 09:30AM  PAVmed Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Aug-21-19 09:30AM  USPTO Grants PAVmed Patent Covering its CarpX Device GlobeNewswire
Aug-15-19 09:30AM  PAVmed Successfully Completes Clinical Safety Study Procedures for CarpX 510(k) Re-submission GlobeNewswire
Aug-07-19 09:30AM  PAVmed to Hold Business Update Conference Call on September 5, 2019 GlobeNewswire
Jul-18-19 03:39PM  What Kind Of Shareholder Appears On The PAVmed Inc.'s (NASDAQ:PAVM) Shareholder Register? Simply Wall St.
Jun-26-19 09:30AM  PAVmed to Join Russell Microcap® Index GlobeNewswire
Jun-24-19 10:46AM  PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck GlobeNewswire
Jun-13-19 09:18AM  Edited Transcript of PAVM earnings conference call or presentation 21-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-21-19 09:30AM  PAVmed Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.48%
May-20-19 09:30AM  PAVmed Announces First Human CarpX Procedures GlobeNewswire
May-06-19 09:30AM  PAVmed to Hold Business Update Conference Call on May 21, 2019 GlobeNewswire
Apr-24-19 09:30AM  PAVmed Reports Excellent DisappEAR Animal Study Results GlobeNewswire
Apr-12-19 09:35AM  PAVmed Announces Registered Direct Offering of its Common Stock GlobeNewswire -8.80%
Apr-04-19 12:25PM  Investors Who Bought PAVmed (NASDAQ:PAVM) Shares A Year Ago Are Now Down 32% Simply Wall St.
09:30AM  PAVmed Reports Fourth Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Mar-21-19 07:30AM  PAVmed to Hold Business Update Conference Call on April 4, 2019 GlobeNewswire
Mar-20-19 07:30AM  PAVmed Announces NextFlo Breakthrough GlobeNewswire
Mar-13-19 08:04AM  PAVmed Announces PortIO Breakthrough GlobeNewswire
Feb-28-19 12:49PM  PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer GlobeNewswire
Feb-26-19 07:30AM  PAVmed Provides Business Update GlobeNewswire
Jan-10-19 07:30AM  PAVmed Provides Business Update GlobeNewswire -14.66%
Dec-17-18 07:00AM  Stonegate Capital Partners Initiates Coverage on PAVmed, Inc. (PAVM) ACCESSWIRE
Nov-29-18 02:29PM  How Much Money Does PAVmed Inc (NASDAQ:PAVM) Make? Simply Wall St.
07:30AM  PAVmed Subsidiary Lucid Diagnostics Files 510(k) Submission with FDA for EsoCheck Cell Collection Device GlobeNewswire
Nov-19-18 08:45AM  Consolidated Research: 2018 Summary Expectations for Moleculin Biotech, Novan, PAVmed, Maui Land & Pineapple, Hallmark Financial Services, and McEwen Mining Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-15-18 07:30AM  PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-01-18 07:30AM  PAVmed to Hold Business Update Conference Call on November 15, 2018 GlobeNewswire
Oct-23-18 07:30AM  PAVmed to Present at Dawson James Securities 4th Annual Small Cap Growth Conference GlobeNewswire
Oct-17-18 07:30AM  PAVmed Provides Business Update GlobeNewswire +6.14%
Sep-25-18 12:49PM  Is PAVmed Incs (NASDAQ:PAVM) Balance Sheet A Threat To Its Future? Simply Wall St. +5.47%
Aug-23-18 09:06AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga -19.57%
Aug-14-18 07:30AM  PAVmed Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Aug-09-18 07:30AM  PAVmed Inc. to Hold SECOND QUARTER FINANCIAL RESULTS AND BUSINESS UPDATE Conference Call on August 22, 2018 GlobeNewswire
Jul-25-18 07:30AM  PAVmed Provides Business Update GlobeNewswire -6.49%
Jul-24-18 07:45AM  Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks ACCESSWIRE -6.10%
Jul-11-18 07:30AM  PAVmed Names Shaun ONeil Chief Commercial Officer Business Wire +7.69%
Jul-09-18 07:30AM  Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements Business Wire
Jun-27-18 08:30AM  PAVmed Provides Business Update Business Wire
Jun-13-18 05:34PM  Dawson James Securities Announces the Closing of Oversubscribed $10,350,000 Rights Offering for PAVmed, Inc. GlobeNewswire
Jun-12-18 04:05PM  PAVmed Closes Oversubscribed Rights Offering for Gross Proceeds of $10,350,000 Business Wire
Jun-08-18 07:30AM  PAVmed to Receive $10.4 Million in Gross Proceeds from Oversubscribed Rights Offering Business Wire
Jun-07-18 10:26AM  What Investors Should Know About PAVmed Incs (NASDAQ:PAVM) Financial Strength Simply Wall St.
Jun-01-18 07:30AM  PAVmed Updates the Terms of Previously Announced Rights Offering Business Wire -14.22%
May-23-18 07:30AM  PAVmed Updates Expected Key Dates for Previously Announced Rights Offering Business Wire -12.54%
May-22-18 07:30AM  PAVmed Reports First Quarter 2018 Financial Results Business Wire
May-18-18 07:30AM  PAVmed Inc. to Hold Business Update Conference Call on May 30, 2018 Business Wire
May-15-18 07:30AM  PAVmed Announces Adjustment to Series Z Warrant Exercise Price Business Wire
May-14-18 07:30AM  PAVmed and Case Western Reserve University Finalize Definitive Licensing Agreement for Groundbreaking EsoCheck Technology Business Wire -8.81%
May-08-18 07:30AM  PAVmed Sets Record Date for Previously Announced Rights Offering Business Wire
Apr-24-18 07:30AM  PAVmed Signs Letter of Intent with Case Western Reserve University to Commercialize Groundbreaking EsoCheck Technology Business Wire
Apr-11-18 07:30AM  PAVmed Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
Apr-05-18 07:30AM  PAVmed Announces Final Results of Offer to Exchange Series W Warrants for Series Z Warrants Business Wire
Apr-04-18 07:30AM  PAVmed Inc. to Hold Business Update Conference Call on April 11, 2018 Business Wire +8.12%
07:30AM  PAVmed Announces Preliminary Results of Offer to Exchange Series W Warrants for Series Z Warrants Business Wire
Apr-02-18 04:00PM  Pavmed to Present at The Microcap Conference ACCESSWIRE
Mar-16-18 04:05PM  PAVmed Announces Extension of Offer to Exchange Series W Warrants for Series Z Warrants Business Wire
Mar-14-18 10:33AM  PAVmed to Present at the 28th Annual Oppenheimer Healthcare Conference Business Wire
Feb-28-18 02:59PM  Who Are The Major Shareholders In PAVmed Inc (NASDAQ:PAVM)? Simply Wall St. +11.69%
Feb-21-18 07:30AM  PAVmed Initiates Offer to Exchange Outstanding Warrants Business Wire
Feb-20-18 03:45PM  Is PAVmed Inc (NASDAQ:PAVM) Overpaying Its CEO? Simply Wall St.
Feb-12-18 07:30AM  PAVmed to Offer Opportunity to Exchange Outstanding Warrants Business Wire +7.79%
Feb-09-18 04:30PM  PAVmed Announces Completion of Offer to Exercise Series W Warrants at a Temporarily Reduced Price Business Wire
Jan-25-18 04:00PM  PAVmed Announces Closing of Over-Allotment Option with Respect to Firm Commitment Common Stock Offering Business Wire
Jan-23-18 06:45PM  Dawson James Securities Announces the Closing of Firm Commitment Underwritten Public Offering for PAVmed Inc. ACCESSWIRE
04:00PM  PAVmed Announces Closing of Firm Commitment Common Stock Offering Business Wire
Jan-19-18 08:25AM  PAVmed Announces Pricing of Firm Commitment Common Stock Offering Business Wire
Jan-18-18 05:56PM  PAVmed Announces Firm Commitment Public Offering of Common Stock Business Wire
Jan-17-18 07:30AM  PAVmed Sets Terms of Previously Announced Rights Offering Business Wire
Jan-11-18 07:30AM  PAVmed Initiates Reduction in Exercise Price of Series W Warrants Business Wire
Dec-28-17 07:30AM  PAVmed Announces Temporary Offer Allowing Warrants to Be Exercised at a Reduced Price Business Wire
Dec-18-17 08:00AM  Fierce Innovation Awards 2017 Recognizes PAVmeds CarpX Device for Technology Innovation Business Wire
Dec-15-17 07:50AM  Wired News CHF Solutions Partners with TRANSMEDIC for Marketing and Distribution of Aquadex FlexFlow(R) System in Singapore ACCESSWIRE
Nov-28-17 08:00AM  PAVmed Files 510(k) Submission with FDA for CarpX Device to Treat Carpal Tunnel Syndrome Business Wire
Nov-21-17 05:39PM  What You Must Know About PAVmed Incs (PAVM) Major Investors Simply Wall St.
Nov-16-17 12:00PM  PAVmed to Host Earnings Call ACCESSWIRE
Nov-15-17 07:30AM  PAVmed Reports Third Quarter 2017 Financial Results Business Wire
Nov-09-17 10:00AM  PAVmed Inc. to Hold Business Update Conference Call on November 16th Business Wire
Oct-10-17 07:30AM  PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference Business Wire
Sep-18-17 07:30AM  PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Aug-14-17 07:30AM  PAVmed Reports Second Quarter 2017 Financial Results Business Wire
Aug-09-17 07:30AM  PAVmed Inc. to Hold Business Update Conference Call on August 17th Business Wire
Jul-05-17 07:30AM  PAVmed Inc. Closes $5 Million Financing Business Wire
Jun-23-17 04:51PM  PAVmed Announces Effectiveness of Form S-1 Resale Registration Statement Business Wire
Jun-22-17 04:01PM  PAVmed to Join Russell Microcap® Index Business Wire
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCGRATH DENNIS MPresident & CFOMay 24Buy1.095,0005,429529,000May 28 04:06 PM
Aklog LishanChairman and CEOMay 23Buy1.1030,00032,850848,413May 28 04:03 PM